The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...

Moderna is one of the pharmaceutical companies best known for developing the messenger RNA vaccine against Covid-19.

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future. One way Moderna has been trying to appease investors and reduce its losses ...

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna (NASDAQ:MRNA) by the ...

RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) ...

The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...

COVID-19 vaccines target emerging variants, offering improved protection. Learn about their effectiveness, timing, and safety ...

The JN.1-adapted COVID-19 vaccines for children aged six months to 11 years have been used up, so starting from yesterday, ...